You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • FRI0449 Analysis of the canadian adalimumab post-marketing observational epidemiological study assessing effectiveness in ankylosing spondylitis (complete-as): association between baseline extra articular manifestations and patient-reported outcomes

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - clinical aspects (other than treatment)
FRI0449 Analysis of the canadian adalimumab post-marketing observational epidemiological study assessing effectiveness in ankylosing spondylitis (complete-as): association between baseline extra articular manifestations and patient-reported outcomes
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bessette L, Haraoui B, Khraishi M, et al
FRI0449 Analysis of the canadian adalimumab post-marketing observational epidemiological study assessing effectiveness in ankylosing spondylitis (complete-as): association between baseline extra articular manifestations and patient-reported outcomes
Annals of the Rheumatic Diseases 2017;76:656.